Global and Japan Psoriasis Therapeutics Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriasis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 TNF Inhibitors
1.2.3 PDE4 Inhibitors
1.2.4 Interleukin Blockers
1.2.5 Others
1.3 Market by Application
1.3.1 Global Psoriasis Therapeutics Market Share by Application: 2020 VS 2026
1.3.2 Oral
1.3.3 Parenteral
1.3.4 Topical
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Psoriasis Therapeutics Market Perspective (2015-2026)
2.2 Global Psoriasis Therapeutics Growth Trends by Regions
2.2.1 Psoriasis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Psoriasis Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Psoriasis Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriasis Therapeutics Players by Market Size
3.1.1 Global Top Psoriasis Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Psoriasis Therapeutics Revenue Market Share by Players (2015-2020)
3.2 Global Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Psoriasis Therapeutics Revenue
3.4 Global Psoriasis Therapeutics Market Concentration Ratio
3.4.1 Global Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriasis Therapeutics Revenue in 2019
3.5 Key Players Psoriasis Therapeutics Area Served
3.6 Key Players Psoriasis Therapeutics Product Solution and Service
3.7 Date of Enter into Psoriasis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriasis Therapeutics Breakdown Data by Type (2015-2026)
4.1 Global Psoriasis Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Psoriasis Therapeutics Forecasted Market Size by Type (2021-2026)
5 Psoriasis Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Psoriasis Therapeutics Historic Market Size by Application (2015-2020)
5.2 Global Psoriasis Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Psoriasis Therapeutics Market Size (2015-2026)
6.2 North America Psoriasis Therapeutics Market Size by Type (2015-2020)
6.3 North America Psoriasis Therapeutics Market Size by Application (2015-2020)
6.4 North America Psoriasis Therapeutics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Psoriasis Therapeutics Market Size (2015-2026)
7.2 Europe Psoriasis Therapeutics Market Size by Type (2015-2020)
7.3 Europe Psoriasis Therapeutics Market Size by Application (2015-2020)
7.4 Europe Psoriasis Therapeutics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Psoriasis Therapeutics Market Size (2015-2026)
8.2 China Psoriasis Therapeutics Market Size by Type (2015-2020)
8.3 China Psoriasis Therapeutics Market Size by Application (2015-2020)
8.4 China Psoriasis Therapeutics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Psoriasis Therapeutics Market Size (2015-2026)
9.2 Japan Psoriasis Therapeutics Market Size by Type (2015-2020)
9.3 Japan Psoriasis Therapeutics Market Size by Application (2015-2020)
9.4 Japan Psoriasis Therapeutics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Psoriasis Therapeutics Market Size (2015-2026)
10.2 Southeast Asia Psoriasis Therapeutics Market Size by Type (2015-2020)
10.3 Southeast Asia Psoriasis Therapeutics Market Size by Application (2015-2020)
10.4 Southeast Asia Psoriasis Therapeutics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Company Details
11.1.2 Astellas Pharma Inc. Business Overview
11.1.3 Astellas Pharma Inc. Psoriasis Therapeutics Introduction
11.1.4 Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2015-2020))
11.1.5 Astellas Pharma Inc. Recent Development
11.2 AstraZeneca plc
11.2.1 AstraZeneca plc Company Details
11.2.2 AstraZeneca plc Business Overview
11.2.3 AstraZeneca plc Psoriasis Therapeutics Introduction
11.2.4 AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2015-2020)
11.2.5 AstraZeneca plc Recent Development
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Details
11.3.2 Boehringer Ingelheim GmbH Business Overview
11.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Introduction
11.3.4 Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2015-2020)
11.3.5 Boehringer Ingelheim GmbH Recent Development
11.4 F. Hofffmann-La Roche
11.4.1 F. Hofffmann-La Roche Company Details
11.4.2 F. Hofffmann-La Roche Business Overview
11.4.3 F. Hofffmann-La Roche Psoriasis Therapeutics Introduction
11.4.4 F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2015-2020)
11.4.5 F. Hofffmann-La Roche Recent Development
11.5 GlaxoSmithKline plc
11.5.1 GlaxoSmithKline plc Company Details
11.5.2 GlaxoSmithKline plc Business Overview
11.5.3 GlaxoSmithKline plc Psoriasis Therapeutics Introduction
11.5.4 GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2015-2020)
11.5.5 GlaxoSmithKline plc Recent Development
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Company Details
11.6.2 Merck & Co., Inc. Business Overview
11.6.3 Merck & Co., Inc. Psoriasis Therapeutics Introduction
11.6.4 Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2015-2020)
11.6.5 Merck & Co., Inc. Recent Development
11.7 Valeant Pharmaceuticals International, Inc.
11.7.1 Valeant Pharmaceuticals International, Inc. Company Details
11.7.2 Valeant Pharmaceuticals International, Inc. Business Overview
11.7.3 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Introduction
11.7.4 Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2015-2020)
11.7.5 Valeant Pharmaceuticals International, Inc. Recent Development
11.8 Biocon Limited
11.8.1 Biocon Limited Company Details
11.8.2 Biocon Limited Business Overview
11.8.3 Biocon Limited Psoriasis Therapeutics Introduction
11.8.4 Biocon Limited Revenue in Psoriasis Therapeutics Business (2015-2020)
11.8.5 Biocon Limited Recent Development
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Details
11.9.2 Eli Lilly and Company Business Overview
11.9.3 Eli Lilly and Company Psoriasis Therapeutics Introduction
11.9.4 Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2015-2020)
11.9.5 Eli Lilly and Company Recent Development
11.10 G & W Laboratories Inc.
11.10.1 G & W Laboratories Inc. Company Details
11.10.2 G & W Laboratories Inc. Business Overview
11.10.3 G & W Laboratories Inc. Psoriasis Therapeutics Introduction
11.10.4 G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2015-2020)
11.10.5 G & W Laboratories Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Psoriasis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of TNF Inhibitors
Table 4. Key Players of PDE4 Inhibitors
Table 5. Key Players of Interleukin Blockers
Table 6. Key Players of Others
Table 7. Global Psoriasis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Psoriasis Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Psoriasis Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Psoriasis Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Psoriasis Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Psoriasis Therapeutics Market Share by Regions (2021-2026)
Table 13. Psoriasis Therapeutics Market Market Trends
Table 14. Psoriasis Therapeutics Market Drivers
Table 15. Psoriasis Therapeutics Market Challenges
Table 16. Psoriasis Therapeutics Market Restraints
Table 17. Global Psoriasis Therapeutics Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Psoriasis Therapeutics Market Share by Players (2015-2020)
Table 19. Global Top Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriasis Therapeutics as of 2019)
Table 20. Global Psoriasis Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Psoriasis Therapeutics Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Psoriasis Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Psoriasis Therapeutics Market Size Share by Type (2015-2020)
Table 26. Global Psoriasis Therapeutics Revenue Market Share by Type (2021-2026)
Table 27. Global Psoriasis Therapeutics Market Size Share by Application (2015-2020)
Table 28. Global Psoriasis Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Psoriasis Therapeutics Market Size Share by Application (2021-2026)
Table 30. North America Psoriasis Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 32. North America Psoriasis Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 34. North America Psoriasis Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Psoriasis Therapeutics Market Share by Country (2015-2020)
Table 36. Europe Psoriasis Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 38. Europe Psoriasis Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Psoriasis Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Psoriasis Therapeutics Market Share by Country (2015-2020)
Table 42. China Psoriasis Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 43. China Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 44. China Psoriasis Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 45. China Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 46. China Psoriasis Therapeutics Market Size by Region (US$ Million) (2015-2020)
Table 47. China Psoriasis Therapeutics Market Share by Region (2015-2020)
Table 48. Japan Psoriasis Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 50. Japan Psoriasis Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Psoriasis Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan Psoriasis Therapeutics Market Share by Country (2015-2020)
Table 54. Southeast Asia Psoriasis Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 56. Southeast Asia Psoriasis Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Psoriasis Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia Psoriasis Therapeutics Market Share by Country (2015-2020)
Table 60. Astellas Pharma Inc. Company Details
Table 61. Astellas Pharma Inc. Business Overview
Table 62. Astellas Pharma Inc. Product
Table 63. Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2015-2020) (US$ Million)
Table 64. Astellas Pharma Inc. Recent Development
Table 65. AstraZeneca plc Company Details
Table 66. AstraZeneca plc Business Overview
Table 67. AstraZeneca plc Product
Table 68. AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2015-2020) (US$ Million)
Table 69. AstraZeneca plc Recent Development
Table 70. Boehringer Ingelheim GmbH Company Details
Table 71. Boehringer Ingelheim GmbH Business Overview
Table 72. Boehringer Ingelheim GmbH Product
Table 73. Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2015-2020) (US$ Million)
Table 74. Boehringer Ingelheim GmbH Recent Development
Table 75. F. Hofffmann-La Roche Company Details
Table 76. F. Hofffmann-La Roche Business Overview
Table 77. F. Hofffmann-La Roche Product
Table 78. F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2015-2020) (US$ Million)
Table 79. F. Hofffmann-La Roche Recent Development
Table 80. GlaxoSmithKline plc Company Details
Table 81. GlaxoSmithKline plc Business Overview
Table 82. GlaxoSmithKline plc Product
Table 83. GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2015-2020) (US$ Million)
Table 84. GlaxoSmithKline plc Recent Development
Table 85. Merck & Co., Inc. Company Details
Table 86. Merck & Co., Inc. Business Overview
Table 87. Merck & Co., Inc. Product
Table 88. Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2015-2020) (US$ Million)
Table 89. Merck & Co., Inc. Recent Development
Table 90. Valeant Pharmaceuticals International, Inc. Company Details
Table 91. Valeant Pharmaceuticals International, Inc. Business Overview
Table 92. Valeant Pharmaceuticals International, Inc. Product
Table 93. Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2015-2020) (US$ Million)
Table 94. Valeant Pharmaceuticals International, Inc. Recent Development
Table 95. Biocon Limited Business Overview
Table 96. Biocon Limited Product
Table 97. Biocon Limited Company Details
Table 98. Biocon Limited Revenue in Psoriasis Therapeutics Business (2015-2020) (US$ Million)
Table 99. Biocon Limited Recent Development
Table 100. Eli Lilly and Company Company Details
Table 101. Eli Lilly and Company Business Overview
Table 102. Eli Lilly and Company Product
Table 103. Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2015-2020) (US$ Million)
Table 104. Eli Lilly and Company Recent Development
Table 105. G & W Laboratories Inc. Company Details
Table 106. G & W Laboratories Inc. Business Overview
Table 107. G & W Laboratories Inc. Product
Table 108. G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2015-2020) (US$ Million)
Table 109. G & W Laboratories Inc. Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Psoriasis Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. TNF Inhibitors Features
Figure 3. PDE4 Inhibitors Features
Figure 4. Interleukin Blockers Features
Figure 5. Others Features
Figure 6. Global Psoriasis Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Oral Case Studies
Figure 8. Parenteral Case Studies
Figure 9. Topical Case Studies
Figure 10. Psoriasis Therapeutics Report Years Considered
Figure 11. Global Psoriasis Therapeutics Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Psoriasis Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Psoriasis Therapeutics Market Share by Regions (2021-2026)
Figure 14. Global Psoriasis Therapeutics Market Share by Players in 2019
Figure 15. Global Top Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriasis Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Psoriasis Therapeutics Revenue in 2019
Figure 17. North America Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Psoriasis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Astellas Pharma Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 45. AstraZeneca plc Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 46. Boehringer Ingelheim GmbH Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 47. F. Hofffmann-La Roche Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 48. GlaxoSmithKline plc Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 49. Merck & Co., Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 50. Valeant Pharmaceuticals International, Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 51. Biocon Limited Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 52. Eli Lilly and Company Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 53. G & W Laboratories Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed